About Teckro

In design, simplicity is achieved by removing instead of adding. At Teckro, we are applying the same concept of design simplicity to address today’s broken clinical trial process.
Gary Hughes - CEO & Co-Founder
Our Story

Every clinical trial starts with a question. At Teckro, we asked “Why can’t clinical trials be more accessible, transparent and simple?”

Teckro was founded in 2015 to answer this question on the belief that immediate access to answers at the point of care improves protocol compliance, accelerates patient enrollment, and reduces cost and error in clinical trials.

Teckro is a suite of clinical trial software that optimizes site performance, increases transparency and oversight, and delivers targeted communications with research site staff and monitors. With Teckro, you can transform your clinical trial protocol from a static document into a critical data source for engagement and trial conduct.

Teckro is currently used by more than 16,000 research sites globally across six continents. Sites using Teckro recruit 50% more patients and have fewer deviations compared to those sites not on Teckro. Global pharmaceutical companies and mid-size biotechs look to Teckro to improve clinical trial performance, thereby accelerating time to market. Given competition for research sites, Teckro allows sponsors to differentiate themselves and to become the “sponsor of choice” to attract the best research staff.

Teckro is used around the world.

Simple and intuitive are key guiding principles at Teckro, and we put the user at the heart of all our product design. As a result, studies are operational on Teckro in just weeks with virtually no user training. And what's more, users love us.

Teckro employs more than 120 staff globally, with Irish offices in Limerick and Dublin and a US-based office in Nashville, Tennessee.

We are celebrating five years of connecting all clinical study stakeholders with answers they need. See more on our anniversary page.

Our Philosophy

At Teckro, we believe that clinical research must be more simple, accessible and transparent.

Tackling complexity has the potential for sweeping impact. If it were simpler, more sites will engage in more studies, and in turn more patients will have access to participate in locations closer to them. With great transparency, trials can be managed safely and early indications can be acted on sooner to protect patients.   

Teckro company values

Simplicity is in our DNA. We empower all of our employees to focus on the right things that will have an impact. By being responsive, we can ensure that the needs of our fellow employees and external stakeholders are considered.  

Our Investors

Teckro is supported by investors who believe in our mission, including prominent venture capital companies:

Our Leadership

Our executive team includes people with deep clinical research experience and those with domain expertise in enterprise software. It is this unique combination of technical and industry experience that gives us the knowledge needed to design simple, useful solutions for clinical research.

Gary Hughes
CEO & Co-Founder
Nigel Hughes
Vice President, Business Development & Co-Founder
Jacek Skrzypiec
Chief Technology Officer & Co-Founder
Professor Brendan M. Buckley MD, DPhil, FRCPI
Chief Medical Officer
John Sexton
Chief Financial Officer
Kelly Brown
Chief Marketing Officer
Amanda Buckley
Chief Operating Officer
Sandra Bläser
Vice President, Customer Success
Brian Deighan
Director, Professional Services
Anita Callan
Vice President, Product
Seb Glowacki
Vice President, Engineering
Kate Penn
Director, Quality Management